ClinConnect ClinConnect Logo
Search / Trial NCT06950099

Advanced Neuroimaging in Idiopathic Intracranial Hypertension

Launched by THOMAS JEFFERSON UNIVERSITY · Apr 22, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Idiopathic Intracranial Hypertension Mri Diffusion Tensor Imaging Iih

ClinConnect Summary

This clinical trial is studying a condition called idiopathic intracranial hypertension (IIH), where there is increased pressure in the brain, leading to symptoms like headaches and vision problems. The trial focuses on understanding how this condition affects the brain's waste clearance system, known as the glymphatic system, and how a procedure called venous sinus stenting (VSS) might help. By using advanced MRI techniques, researchers aim to see how changes in the brain's structure and function before and after VSS relate to patients' symptoms and overall health.

To be eligible for the trial, participants must be adults aged 18 to 75 who have IIH that hasn't responded to other treatments and are planning to undergo venous sinus stenting. Unfortunately, individuals with certain medical histories, such as past head trauma or specific pain conditions, will not be able to participate. Those who join the study can expect to undergo a series of noninvasive brain imaging tests to help gather important information about their condition. Ultimately, the goal is to improve understanding and treatment of IIH, which could lead to better care for patients dealing with this challenging condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Refractory IIH patients who require and plan to have a venous sinus stenting
  • Exclusion Criteria:
  • History of head trauma and shunting or leak repair
  • Major concurrent, active non-cephalic pain syndrome
  • Contradictions for MRIs

About Thomas Jefferson University

Thomas Jefferson University is a distinguished academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to advancing healthcare through research and education. As a clinical trial sponsor, the university leverages its extensive resources and interdisciplinary expertise to conduct innovative research aimed at improving patient outcomes. With a focus on translational medicine, Thomas Jefferson University collaborates with various stakeholders, including healthcare professionals, industry partners, and regulatory agencies, to ensure the highest standards of scientific rigor and ethical conduct in its clinical trials. The institution is dedicated to fostering a culture of excellence in research, ultimately contributing to the advancement of medical knowledge and the development of novel therapeutic interventions.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Hsiangkuo Yuan, MD PhD

Principal Investigator

Thomas Jefferson University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported